Navigation Links
Innovative BioDefense Introduces Zylast Antiseptic Lotion
Date:7/30/2013

LAKE FOREST, Calif., July 30, 2013 /PRNewswire/ -- Innovative BioDefense Inc., the developer of a full product line of Zylast™ antiseptic products for use in healthcare, nursing, food preparation, schools, cruise ships, and homes, introduces Zylast Lotion, available in 2 & 8 oz bottles, or in ADA-approved, wall-mounted dispensers.  Zylast Lotion is protected by patents and other intellectual property and can be viewed at http://bit.ly/12nLtjt

In clinical and laboratory studies, Zylast Lotion has been demonstrated to kill very rapidly a wide spectrum of germs, including E. Coli (99.9999%), S. Aureus (99.9997%), K. Pneumoniae (99.9999%), and S. Pyogenes (99.9999%), while being persistent for six hours after application.  The active ingredient is benzethonium chloride (BZT, 0.2%), together with a proprietary blend of adjuvants that enhance the persistence and rapid kill.  Innovative BioDefense has posted Time-Kill and Persistence papers on its website at www.zylast.com with information on the study results.

Clinical studies have shown that use of Zylast Lotion reduces illness absenteeism in schools by 41.6% among students and 24.7% among teachers and staff.  The Lotion is all-natural, water-based, and Triclosan-free.

"First, the Zylast products are persistent for six hours, so children are protected beyond the 15-second lifespan of an alcohol sanitizer.  Second, the Zylast Lotion is effective against pathogens like the Norovirus, rotavirus, and the common cold – some of the most prevalent diseases among children, and germs against which alcohol sanitizers are relatively ineffective.  Finally, the product is water-based and moisturizes the hands, so children and staff actually like using it, which greatly improves compliance." – Dr. Beth McNichol

Zylast Lotion should be used by healthcare and dental workers, teachers and school personnel, food preparers and servers, parents and in long-term care facilities in order to help assure that harmful bacteria and viruses are killed and the likelihood of contagion reduced.

The retail cost of Zylast Lotion is $71.52 for a case (24 bottles) of 2 ounce bottles or $2.98 a bottle; $106.56 for a case (12) of 8 ounce bottles or $8.88 a bottle; or 178.26 for a case (six) of 1,000 ml (33.8 ounce) cartridges for wall mounting or $29.71 a cartridge. Automatic and manual dispensers are also available.

The product is available for immediate delivery and can be ordered by visiting www.zylastdirect.com.

About Zylast
Zylast™ is a developer, manufacturer and marketer of a full line of antiseptic products for use by healthcare professionals, businesses and consumers.  Zylast products, based on proprietary and patented combinations of pharmaceutical ingredients, are owned by Innovative BioDefense Inc., a privately held company headquartered in Lake Forest, CA. 

For more information, visit www.zylast.com.


'/>"/>
SOURCE Innovative BioDefense Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Innovative Cancer Treatment Supported by NICE
2. Innovative Krebsbehandlung wird von NICE unterst├╝tzt
3. UBM Canon and MD+DI Proudly Announce 27 Innovative Products as Winners of the 2013 Medical Design Excellence Awards
4. Andrews Institute offers innovative technology for spine surgery
5. Sirtex To Distribute Surefire Medicals Innovative Infusion System in Australia and Asia Pacific Markets
6. Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies
7. Romanoff Joins Innovative Statewide Program to Combat Abuse of Prescription Pain Medications
8. Neiman Center Issues Policy Brief Outlining Innovative Health Care Payment Models to Provide Cost-Effective Specialty Care for Patients
9. BlueBin Inc. Launches to Deliver Innovative Overhaul for Ailing Healthcare Supply Chain
10. VUCA Health Announces Rapid Adoption of its MedsOnCue Digital Patient Engagement Solution Supporting Health Literacy by Innovative Pharmacies across 19 States
11. TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... and EDMONTON, Alberta , July ... and the University of Alberta in ... in Nature,s partner journal, Schizophrenia 1 , demonstrating ... instances of schizophrenia with 74% accuracy. This retrospective ... of specific symptoms in schizophrenia patients with significant ...
(Date:7/21/2017)... , July 21, 2017  Endo International plc (NASDAQ: ... a comprehensive review of its manufacturing network, the Company ... distribution facilities in Huntsville, Alabama . ... place over the next 12 to 18 months. The ... by declining volumes of commoditized products and these restructuring ...
(Date:7/20/2017)... , July 20, 2017  Prime Therapeutics LLC (Prime) ... Gavras , M.D., following today,s Institute for Clinical and Economic ... on the effectiveness and value of abuse-deterrent formulations (ADF) ... the policy roundtable at the meeting. ... a material cost benefit to the use of abuse-deterrent formulations ...
Breaking Medicine Technology:
(Date:7/24/2017)... ... 2017 , ... SignatureCare Emergency Center is looking to award their ... to a deserving student. Get your applications in now as the deadline is ... Castillo who is a nursing student at Prairie View A&M University with a 3.45 ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... Oakland, California effectively destroyed the construction site and threatened numerous homes and businesses ... 7th article on NBCLosAngeles.com. Los Angeles Area consulting firm Fire Protection ...
(Date:7/24/2017)... CLARA, CA (PRWEB) , ... July 24, 2017 , ... ... and financial organizations, today announced it has partnered with WALLIX to expand ... Special Publication 800-171 . , There are a number of ways to address the ...
(Date:7/24/2017)... California (PRWEB) , ... July 24, 2017 , ... ... of autologous fat (adipose) transfer systems announces the issuance of United States Patent ... patent) for its adipose filtration technology. The '398 and '324 patents cover ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... sleep management solution focused on delivering end-to-end sleep health care at scale, ... Recent literature shows that adherence rates for positive airway pressure (PAP) therapy, the ...
Breaking Medicine News(10 mins):